MOHMOHHealthcare · Healthcare Plans

MOH Stock Forecast: Molina Healthcare, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$209
−0.15% on the day

The 19 Wall Street analysts covering Molina Healthcare, Inc. hold a median 12-month price target of $209 — -0.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 36 of 100 as at 14 Oct 2026 — in the lower half.

Market cap
$10.9B
Ticker Nerd rank
36 / 100
Median analyst target
$209
Analysts covering
19
Revenue$10.9B−4.8% y/y
Operating income$145.0M
Net income$60.0M
Free cash flow−$324.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+7.4%
1M
−2.3%
YTD
+20.5%
1Y
+7.3%
From 52W high
−13.9%
From 52W low
+70.6%
$123
$243
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

MOH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Molina Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
36 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
87
Value
72
Issuance
66
Revisions
54
Accruals
48
Momentum
46
Growth
26
Quality
20
Size
14

Volatility (87): The share price has been relatively steady.

Quality (20): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

MOH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MOH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$150$200$250Jan 26Apr 26Jul 26Oct 26MOHHigh $266Median $209Low $147

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says19 analysts
4 Buy14 Hold1 Sell
Low $147Median $209High $266

The green dot is the last close — the median target sits −0.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 5 moved it down.

DateFirmActionRatingTarget
28 July 2026Wells FargoMaintainsEqual-Weight$235 → $220
24 July 2026BarclaysMaintainsUnderweight$184 → $180
24 July 2026RBC CapitalMaintainsSector Perform$248 → $218
24 July 2026Truist SecuritiesMaintainsHold$250 → $225
14 July 2026TD CowenMaintainsHold—
14 July 2026TD CowenMaintainsHold$163 → $230
14 July 2026Truist SecuritiesMaintainsHold$205 → $250
14 July 2026Truist SecuritiesMaintainsHold—
13 July 2026Wells FargoMaintainsEqual-Weight$159 → $235
13 July 2026Wells FargoMaintainsEqual-Weight—
9 July 2026BarclaysMaintainsUnderweight$199 → $184
9 July 2026BarclaysMaintainsUnderweight—
9 July 2026RBC CapitalMaintainsSector Perform—
9 July 2026RBC CapitalMaintainsSector Perform$216 → $248
23 June 2026RBC CapitalInitiatesSector Perform—
8 June 2026JP MorganMaintainsNeutral—
4 June 2026Morgan StanleyMaintainsEqual-Weight—
26 May 2026BarclaysMaintainsUnderweight—
22 May 2026UBSMaintainsNeutral—
11 May 2026BairdMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MOH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

MOH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, Molina Healthcare, Inc. returned +7.3% against +17.5% for the S&P 500, dividends included.

MOH vs S&P 500, last 12 monthsTotal return, rebased to 100
60708090100110120130Jan 26Apr 26Jul 26Oct 26MOHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

MOH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.9%
Analysts raising
1
Analysts cutting
0
Fundamentals

Molina Healthcare, Inc. (MOH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
2327.8×

Cheaper than 1% of US stocks

Price / sales
0.3×

Cheaper than 90% of US stocks

Price / book
2.6×

Cheaper than 35% of US stocks

EV / EBITDA
14.6×

Cheaper than 23% of US stocks

Growth & margins
Revenue growth (YoY)
−5.7%

Higher than 19% of US stocks

Earnings growth (YoY)
−76.5%

Higher than 5% of US stocks

Gross margin
8.5%

Higher than 8% of US stocks

Operating margin
1.4%

Higher than 48% of US stocks

Net margin
−0.0%

Higher than 30% of US stocks

Returns & dividend
Return on equity
−0.2%

Higher than 44% of US stocks

Return on assets
1.2%

Higher than 52% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Molina Healthcare, Inc. (MOH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Molina Healthcare, Inc. has a market value of $10.9B and an enterprise value of $5.7B.

  • Revenue in the twelve months to 30 June 2026: $44.5B. The latest quarter shrank 5.7% year on year.

  • Net income over the same four quarters: −$7.0M, a −0.0% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.22.

  • Free cash flow in the twelve months to 30 June 2026: $271.0M, after $94.0M of capital spending.

  • Molina Healthcare, Inc. spent $500.0M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 52.0M.

  • Trailing P/E: 2327.8×; forward P/E: 21.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Molina Healthcare, Inc. employs 19,000 people — $2.3M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Oct 2026

Data provided by Twelve Data

Peers

MOH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
MOHMolina Healthcare, Inc.$10.9B
36
OSCROscar Health, Inc.$10.2B
91
CNCCentene Corp.$34.5B
93
CLOVClover Health Investments Corp.$2.5B
72
HUMHumana, Inc.$51.4B
48
PGNYProgyny, Inc.$2.2B
97
ALHCAlignment Healthcare, Inc.$1.7B
60

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Molina Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest MOH news & analysis

Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research · 14 Oct 2026negative

Zacks Investment Research says Molina lacks the two key ingredients it considers supportive of a likely earnings beat in its upcoming report. The headline says analysts estimate a decline in earnings.

Why it matters — MOH watchers may find the earnings outlook relevant as the company approaches its upcoming report.

Centene vs. Molina: Which Managed Care Stock Has More Upside?

Zacks Investment Research · 12 Oct 2026negative

Zacks Investment Research says Centene’s diversified business, improving margins and lower valuation give it an edge over Molina, citing stronger earnings prospects and greater upside potential for Centene.

Why it matters — The comparison presents a less favorable outlook for Molina relative to Centene based on the factors cited.

Molina Healthcare of Nebraska Donates $30,000 to Support Lead Testing in Over 20 Rural Counties

Business Wire · 1 Oct 2026positive

Molina Healthcare of Nebraska donated $30,000 to support lead testing across more than 20 rural counties in the state. The donation was announced in a Business Wire release.

Why it matters — A MOH watcher would care because the donation reflects the company's community engagement and investment in rural health initiatives, which can burnish its public reputation.

Molina Healthcare of Michigan and The MolinaCares Accord Award $160,000 in Grants to Genesee County-Area Organizations Addressing Social Determinants of Health

Business Wire · 28 Sept 2026positive

Molina Healthcare of Michigan, along with The MolinaCares Accord, awarded $160,000 in grants to Genesee County-area organizations working to address social determinants of health. The announcement was made in Flint, Michigan.

Why it matters — The grants signal Molina's continued community investment and focus on social determinants of health, which reflects positively on its corporate engagement and reputation.

Should Value Investors Buy Molina Healthcare (MOH) Stock?

Zacks Investment Research · 28 Sept 2026neutral

Zacks Investment Research published an article examining whether Molina Healthcare (MOH) is a suitable value-stock pick. The piece highlights the Zacks Rank system, which relies on earnings estimates and estimate revisions, while also considering value, growth, and momentum trends to identify strong candidates.

Why it matters — MOH watchers would care because the article evaluates the stock's attractiveness through Zacks' earnings-estimate and value/growth/momentum framework, offering perspective on how the company is being assessed by investors.

FAQ

Frequently asked questions about MOH stock

What is the MOH stock price forecast for 2026-2027?

The 19 Wall Street analysts covering Molina Healthcare, Inc. have a median 12-month price target of $209, with estimates ranging from $147 to $266. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MOH stock a buy right now?

Of the 19 analysts covering Molina Healthcare, Inc., 4 rate it a Buy, 14 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Molina Healthcare, Inc. 36 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MOH?

As at 14 Oct 2026, Molina Healthcare, Inc. ranks 36 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (87 of 100).

Will MOH stock go up?

No one can know that. What the data says: the median 12-month target from 19 analysts implies -0.1% from the last close, and Ticker Nerd's factor model ranks Molina Healthcare, Inc. 36 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MOH stock forecast for 2030?

No analyst covering Molina Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MOH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $147 to $266 over the next 12 months.

How has MOH stock performed over the past year?

Molina Healthcare, Inc. returned +7.3% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Molina Healthcare, Inc. do?

Molina Healthcare Inc. is a managed care company that provides health coverage and related services to low-income individuals and families through Medicaid, Medicare, and state insurance marketplace programs.

What is the latest news on MOH?

The most recent item we track (Zacks Investment Research, 14 Oct 2026): "Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out for". Zacks Investment Research says Molina lacks the two key ingredients it considers supportive of a likely earnings beat in its upcoming report. The headline says analysts estimate a decline in earnings.

Company

About Molina Healthcare, Inc.

Molina Healthcare Inc. is a managed care company that provides health coverage and related services to low-income individuals and families through Medicaid, Medicare, and state insurance marketplace programs. The company focuses on government-sponsored healthcare, offering Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans. Its business is organized across Medicaid, Medicare, Marketplace, and Other segments, reflecting a model centered on administering public and subsidized health benefits. Molina Healthcare Inc. serves members across multiple U.S. states and plays a significant role in coordinating access to medical care, benefits administration, and healthcare network management. Founded in 1980 and headquartered in Long Beach, California, Molina Healthcare Inc. is a major participant in the U.S. managed healthcare market.

CEO Mr. Joseph Michael Zubretsky · 19,000 employees · United States · https://www.molinahealthcare.com